Determinants of perinatal HIV-1 transmission

Clinical Obstetrics and Gynecology

Volumn 39, Issue 2, 1996, Pages 386-395

  Orloff, Sherry L ^a   Simonds, R J ^a   Steketee, Richard W ^a   St Louis, Michael E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

BREAST FEEDING; CESAREAN SECTION; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INFECTION PREVENTION; INFECTION RISK; LYMPHOCYTE COUNT; MATERNAL WELFARE; PLACENTAL TRANSFER; REVIEW; RISK ASSESSMENT; RISK FACTOR; STRAIN DIFFERENCE; VAGINAL DELIVERY; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, VERTICAL; FEMALE; FORECASTING; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; RESEARCH; RISK FACTORS; TIME FACTORS;

EID: 0029885820     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199606000-00011     Document Type: Review

References (39)

1. Centers for Disease Control and Prevention. Unexplained immunodeficiency and opportunistic infections in infants. MMWR. 1982;31:665-667.
2. Dabis F, Msellati P, Dunn D, Lepage P, Newell ML, Peckham C, et al. Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues Ghent (Belgium), 17-20 February 1992. The Working Group on Mother-to-Child Transmission of HIV. AIDS. 1993;7: 1139-1148.
3. Bryson YJ, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1 [letter]. N Engl J Med. 1992;327:1246-1247.
4. Simonon A, Lepage P, Karita E, Hitimana DG, Dabis F, Msellati P, et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. J Acquir Immune Defic Syndr. 1994;7: 952-957.
5. Sprecher S, Soumenkoff G, Puissant F, Degueldre M. Vertical transmission of HIV in 15-week fetus [letter]. Lancet. 1986;2:288-289.
6. Rouzioux C, Costagliola D, Burgard M, Blanche S, Mayaux MJ, Griscelli C, et al. Timing of mother-to-child HIV-1 transmission depends on maternal status. AIDS. 1993;7(Suppl 2):S49-S52.
7. Goedert JJ, Duliege AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-1 infection for first-born twins. Lancet. 1991;338:1471-1475.
8. Dunn DT, Newell ML, Mayaux MJ, Kind C, Hutto C, Goedert JJ, et al. Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. J Acquir Immune Defic Syndr. 1994;7:1064-1066.
9. Datta P, Embree JE, Kreiss JK, Ndinya-Achola JO, Braddick M, Temmerman M, et al. Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis. 1994;170: 1134-1140.
10. Report of a Consensus Workshop, Siena, Italy, January 17-18, 1992. Maternal factors involved in mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr. 1992;5:1019-1029.
11. Blanche S, Mayaux MJ, Rouzioux C, Teglas JP, Firtion G, Monpoux F, et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med. 1994;330:308-312.
12. St Louis ME, Kamenga M, Brown C, Nelson AM, Manzila T, Batter V, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA. 1993;269:2853-2859.
13. Weiser B, Nachman S, Tropper P, Viscosi KH, Grimson R, Baxter G, et al. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA. 1994;91:8037-8041.
14. Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet. 1994;343:1593-1597.
15. Parekh BS, Shaffer N, Pau CP, Abrams E, Thomas P, Pollack H, et al. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. AIDS. 1991;5:1179-1184.
16. Scarlatti G, Albert J, Rossi P, Hodara V, Biraghi P, Muggiasca L, et al. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis. 1993;168:207-210.
17. Kliks SC, Wara DW, Landers DV, Levy JA. Features of HIV-1 that could influence maternal-child transmission. JAMA. 1994;272: 467-474.
18. Wolinsky SM, Wike CM, Korber BT, Hutto C, Parks WP, Rosenblum LL, et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science. 1992;255:1134-1137.
19. Scarlatti G, Leitner T, Halapi E, Wahlberg J, Marchisio P, Clerici-Schoeller MA, et al. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci USA. 1993;90:1721-1725.
20. Mulder-Kampinga GA, Kuiken C, Dekker J, Scherpbier HJ, Boer K, Goudsmit J. Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission. J Gen Virol. 1993;74:1747-1756.
21. Lewis SH, Reynolds-Kohler C, Fox HE, Nelson JA. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet. 1990;335:565-568.
22. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet. 1992;339:1007-1012.
23. Villari P, Spino C, Chalmers TC, Lau J, Sacks HS. Cesarean section to reduce perinatal transmission of human immunodeficiency virus. Online Journal of Current Clinical Trials. 1993; Doc No 74.
24. Minkoff H, Burns DN, Landesman S, Youchah J, Goedert JJ, Nugent RP, et al. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol. 1995;173:585-589.
25. Burns DN, Landesman S, Muenz LR, Nugent RP, Goedert JJ, Minkoff HW, JH, et al. Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. J Acquir Immune Defic Syndr. 1994;7:718-726.
26. Boyer PJ, Dillon M, Navaie M, Deveikis A, Keller M, O'Rourke S, et al. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA. 1994;271:1925-1930.
27. Viscarello RR, Copperman AB, DeGennaro NJ. Is the risk of perinatal transmission of human immunodeficiency virus increased by the intrapartum use of spiral electrodes or fetal scalp pH sampling? Am J Obstet Gynecol. 1994;170:740-743.
28. Ziegler JB, Cooper DA, Johnson RO, Gold J. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet. 1985;1:896-898.
29. The European Collaborative Study Group. Risk factors for mother-to-child transmission of HIV-1. Lancet. 1992;339:1007-1012.
30. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992;340:585-588.
31. Ekpini E, Wiktor SZ, Sibailly T, Diaby L, Brattegaard K, Whitaker P, et al. Late postnatal mother-to-child HIV transmission in Abidjan,Cote D'Ivoire. Tenth International Conference on AIDS 1994; Yokahama, Japan, August 7-12, 1994; Abstract 218C.
32. Mayaux MJ, Blanche S, Rouzioux C, Le Chenadec J, Chambrin V, Firtion G, et al. Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:188-194.
33. Bulterys M, Chao A, Dushimimana A, Habimana P, Nawrocki P, Kurawige JB, et al. Multiple sexual partners and mother-to-child transmission of HIV-1. AIDS. 1993;7: 1639-1645.
34. Siriwasin W, Roongpisuthipong A, Wasi C, Kaewchaiyo G, Mangclaviraj Y, Laosakkitiboran J, et al. Perinatal HIV-1 transmission among women seroconverting during pregnancy. Bangkok, Thailand: Chiang Mai 3rd International Conference on AIDS in Asia and the Pacific, 1995; Abstract.
35. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331: 1173-1180.
36. Centers for Disease Control and Prevention. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR. 1994;43: (RR-11).
37. World Health Organization. Consensus statement from the WHO/UNICEF consultation on HIV transmission and breastfeeding. Wkly Epidemiol Rec. 1992;24:177-179.
38. Biggar RJ, Miotti P, Mtimivalye L, Waters D, Taha T, et al. An intervention trial to reduce mother-to-child HIV transmission. AIDS Res Hum Retroviruses. 1995;11: S78.
39. Centers for Disease Control and Prevention. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR. 1995;44.